ROSUVASTATIN CALCIUM Intermediates CAS No 124752-23-4 Pharmaceutical Intermediates
overview
Tert-Butyl (4R-Cis)-6-carboxaldehyde-2,2-dimethyl-1,3-dioxane-4-acetate is a novel compound that is an important intermediate in the synthesis of various pharmaceuticals. Its unique structure allows for targeted interactions within biological systems, making it a valuable asset for drug development.
This compound is particularly important in the development of new therapeutic agents for a range of diseases, where it may play a role in modulating specific biological pathways.
Physical and Chemical Properties
- Solubility: Soluble in organic solvents such as methanol and dichloromethane, with limited solubility in water, providing a wide range of formulation possibilities.
- Melting Point: Approximately 50-55°C, indicating stability under standard laboratory conditions.
These properties not only enhance the performance of drug formulations, but also ensure that tert-butyl (4R-Cis)-6-carboxaldehyde-2,2-dimethyl-1,3-dioxane-4-acetate can be effectively utilized in a variety of applications without compromising stability or efficacy.
1. Targeted therapeutic effect: The unique structure of the compound can interact specifically with biological targets, thereby enhancing its therapeutic effect in treating various diseases.
2. Multiple formulation options: Its solubility properties make it easy to incorporate into a variety of dosage forms, including tablets, capsules and injections, providing manufacturers with flexibility in product development.
3. Regulatory Compliance: Our manufacturing processes adhere to international quality standards, ensuring that tert-Butyl (4R-Cis)-6-carboxaldehyde-2,2-dimethyl-1,3-dioxane-4-acetate meets all regulatory requirements for pharmaceutical products.
4. Cost-effective: As a factory integrating production and trading, we have streamlined our operation process and offer competitive prices without compromising quality, making this compound an economical choice for pharmaceutical companies.
5. Committed to Research and Development: Our dedicated research team is constantly exploring new applications and formulations for this compound, ensuring we remain at the forefront of pharmaceutical innovation.
At our integrated facility, we are committed to maintaining the highest standards of quality and innovation. Our state-of-the-art production facility is equipped with advanced technologies that allow us to produce tert-butyl (4R-cis)-6-carboxaldehyde-2,2-dimethyl-1,3-dioxane-4-acetate with precision and consistency. Our team of researchers and quality control experts work diligently to ensure that every batch of our product meets the highest standards of purity and potency.
We understand the importance of a reliable supply chain in the pharmaceutical industry. Therefore, we have built a strong logistics and distribution network to ensure timely delivery of products to customers around the world. Our customer-centric approach means we are always ready to work with our partners to meet their specific needs and requirements.
In conclusion, Tert-Butyl (4R-cis)-6-carboxaldehyde-2,2-dimethyl-1,3-dioxane-4-acetate is the top choice for pharmaceutical manufacturers seeking a high-quality, highly effective and versatile compound.
With its excellent physical and chemical properties, coupled with our commitment to quality and innovation, we believe this compound will enhance your product offerings and meet the needs of the evolving pharmaceutical landscape.
Choose tert-Butyl (4R-cis)-6-carboxaldehyde-2,2-dimethyl-1,3-dioxane-4-acetate for your next formulation and experience the difference in quality and performance.